The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Relatório |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180 |
Resumo: | ABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome. |
id |
RCAP_c41051bf450f88e9d25dc4b670c82f08 |
---|---|
oai_identifier_str |
oai:scielo:S0872-01692022000300180 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful CasePeritoneal Dialysis/adverse effectsPeritoneal Fibrosis/diagnosisPeritoneal Fibrosis/etiologyPeritoneal Fibrosis/surgeryPeritoneal Fibrosis/therapyTamoxifen/therapeutic useABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome.Sociedade Portuguesa de Nefrologia2022-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/reporttext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180Portuguese Journal of Nephrology & Hypertension v.36 n.3 2022reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180Sousa,Círia Leandra Martins dePereira,Pedro Manuel ReisFrancisco,José António Teixeira da SilvaPrata,CatarinaCastro,Rui ArlindoMorgado,Teresa Margaridainfo:eu-repo/semantics/openAccess2024-02-06T17:05:14Zoai:scielo:S0872-01692022000300180Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:19:08.281742Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
title |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
spellingShingle |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case Sousa,Círia Leandra Martins de Peritoneal Dialysis/adverse effects Peritoneal Fibrosis/diagnosis Peritoneal Fibrosis/etiology Peritoneal Fibrosis/surgery Peritoneal Fibrosis/therapy Tamoxifen/therapeutic use |
title_short |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
title_full |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
title_fullStr |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
title_full_unstemmed |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
title_sort |
The Role of Enterolysis and Tamoxifen in Encapsulating Peritoneal Sclerosis: A Successful Case |
author |
Sousa,Círia Leandra Martins de |
author_facet |
Sousa,Círia Leandra Martins de Pereira,Pedro Manuel Reis Francisco,José António Teixeira da Silva Prata,Catarina Castro,Rui Arlindo Morgado,Teresa Margarida |
author_role |
author |
author2 |
Pereira,Pedro Manuel Reis Francisco,José António Teixeira da Silva Prata,Catarina Castro,Rui Arlindo Morgado,Teresa Margarida |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Sousa,Círia Leandra Martins de Pereira,Pedro Manuel Reis Francisco,José António Teixeira da Silva Prata,Catarina Castro,Rui Arlindo Morgado,Teresa Margarida |
dc.subject.por.fl_str_mv |
Peritoneal Dialysis/adverse effects Peritoneal Fibrosis/diagnosis Peritoneal Fibrosis/etiology Peritoneal Fibrosis/surgery Peritoneal Fibrosis/therapy Tamoxifen/therapeutic use |
topic |
Peritoneal Dialysis/adverse effects Peritoneal Fibrosis/diagnosis Peritoneal Fibrosis/etiology Peritoneal Fibrosis/surgery Peritoneal Fibrosis/therapy Tamoxifen/therapeutic use |
description |
ABSTRACT Encapsulating peritoneal sclerosis (EPS) is a rare complication of peritoneal dialysis which mortality can reach 50%. The usual treatment involves suspension of the technique, medical treatment, and surgical enterolysis. We report the case of a 36-year-old female who undergone continuous ambulatory peritoneal dialysis without complications for 10 years. She presented at the emergency department with abdominal pain and a diagnosis of peritonitis was assumed. The patient developed a systemic inflammatory response, and her abdominal computer tomography (CT) scan showed multiple parietal calcifications. After multiple broad-spectrum antibiotics, an undetermined febrile syndrome persisted, and parenteral nutrition was started. An EPS diagnosis was established and treatment with tamoxifen was proposed. Exploratory laparoscopy was decided, and the intraoperative findings were consistent with EPS. The patient was submitted to extensive enterolysis. A clinical improvement led to a discharge after 60 days of hospitalization. After more than 30 months with tamoxifen, she remains on hemodialysis and doing well. There are no randomized controlled trials to guide EPS management and the following procedures are more difficult to decide, who makes these reports important to the reflection. We describe a case of successful treatment of EPS, with a very severe presentation. The management with enterolysis and tamoxifen contributed decisively to this outcome. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/report |
format |
report |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180 |
url |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692022000300180 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
publisher.none.fl_str_mv |
Sociedade Portuguesa de Nefrologia |
dc.source.none.fl_str_mv |
Portuguese Journal of Nephrology & Hypertension v.36 n.3 2022 reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1817550060570804224 |